Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.2 - $3.5 $895,440 - $2.61 Million
746,200 Added 197.15%
1,124,700 $3.16 Million
Q2 2024

Aug 14, 2024

BUY
$0.62 - $1.31 $108,562 - $229,381
175,100 Added 86.09%
378,500 $465,000
Q1 2024

May 15, 2024

SELL
$0.72 - $1.02 $147,312 - $208,692
-204,600 Reduced 50.15%
203,400 $160,000
Q4 2023

Feb 14, 2024

SELL
$0.88 - $1.13 $43,208 - $55,482
-49,100 Reduced 10.74%
408,000 $387,000
Q3 2023

Nov 14, 2023

BUY
$0.78 - $1.56 $94,224 - $188,448
120,800 Added 35.92%
457,100 $493,000
Q2 2023

Aug 14, 2023

SELL
$0.73 - $1.07 $42,048 - $61,632
-57,600 Reduced 14.62%
336,300 $302,000
Q1 2023

May 15, 2023

SELL
$0.82 - $1.34 $628,612 - $1.03 Million
-766,600 Reduced 66.06%
393,900 $334,000
Q4 2022

Feb 14, 2023

BUY
$0.87 - $1.86 $542,619 - $1.16 Million
623,700 Added 116.19%
1,160,500 $1.08 Million
Q3 2022

Nov 14, 2022

BUY
$1.7 - $3.4 $192,780 - $385,560
113,400 Added 26.78%
536,800 $913,000

Others Institutions Holding CLOV

About CLOVER HEALTH INVESTMENTS, CORP.


  • Ticker CLOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Healthcare Plans
  • Shares Outstandng 383,248,000
  • Market Cap $1.29B
  • Description
  • Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health In...
More about CLOV
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.